Primary amoebic meningoencephalitis is a rare but fatal central nervous system (CNS) disease caused by the "brain-eating amoeba" Naegleria fowleri. A major obstacle is the requirement for drugs with the ability to cross the blood-brain barrier, which are used in extremely high doses, cause severe side effects, and are usually ineffective. We discovered that the 4-aminomethylphenoxy-benzoxaborole AN3057 exhibits nanomolar potency against N. fowleri, and experimental treatment of infected mice significantly prolonged survival and demonstrated a 28% relapse-free cure rate.

Department of Parasitology Faculty of Science Charles University BIOCEV Vestec Czech Republic

Institute of Biotechnology Czech Academy of Sciences BIOCEV Vestec Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23004154

003      

CZ-PrNML

005      

20230425141126.0

007      

ta

008      

230418s2023 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1128/aac.01506-22 $2 doi

035    __

$a (PubMed)36688657

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Ženíšková, Kateřina $u Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic

245    14

$a The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis / $c K. Ženíšková, J. Mach, D. Arbon, J. Štursa, L. Werner, M. Zoltner, R. Sutak

520    9_

$a Primary amoebic meningoencephalitis is a rare but fatal central nervous system (CNS) disease caused by the "brain-eating amoeba" Naegleria fowleri. A major obstacle is the requirement for drugs with the ability to cross the blood-brain barrier, which are used in extremely high doses, cause severe side effects, and are usually ineffective. We discovered that the 4-aminomethylphenoxy-benzoxaborole AN3057 exhibits nanomolar potency against N. fowleri, and experimental treatment of infected mice significantly prolonged survival and demonstrated a 28% relapse-free cure rate.

650    _2

$a zvířata $7 D000818

650    _2

$a myši $7 D051379

650    12

$a amébiáza $x farmakoterapie $7 D000562

650    12

$a protozoární infekce centrálního nervového systému $x farmakoterapie $7 D020808

650    12

$a Naegleria fowleri $7 D016848

650    _2

$a hematoencefalická bariéra $7 D001812

650    12

$a meningoencefalitida $7 D008590

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Mach, Jan $u Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic $1 https://orcid.org/0000000247779280 $7 xx0153987

700    1_

$a Arbon, Dominik $u Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic

700    1_

$a Štursa, Jan $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic

700    1_

$a Werner, Lukáš $u Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic

700    1_

$a Zoltner, Martin $u Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic $1 https://orcid.org/000000020214285X

700    1_

$a Sutak, Robert $u Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic $1 https://orcid.org/0000000155881683 $7 xx0254258

773    0_

$w MED00009215 $t Antimicrobial agents and chemotherapy $x 1098-6596 $g Roč. 67, č. 2 (2023), s. e0150622

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36688657 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20230418 $b ABA008

991    __

$a 20230425141123 $b ABA008

999    __

$a ok $b bmc $g 1924675 $s 1190363

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 67 $c 2 $d e0150622 $e 20230123 $i 1098-6596 $m Antimicrobial agents and chemotherapy $n Antimicrob Agents Chemother $x MED00009215

LZP    __

$a Pubmed-20230418